Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
United Therapeutics |
---|---|
Information provided by: | United Therapeutics |
ClinicalTrials.gov Identifier: | NCT00848107 |
This open label extension trial will allow ongoing treatment of subjects who participated in the randomized controlled trials, and will provide long term information about the safety of treprostinil diethanolamine SR in this patient population
Condition | Intervention |
---|---|
Systemic Sclerosis |
Drug: treprostinil diethanolamine |
Study Type: | Interventional |
Study Design: | Treatment, Open Label, Active Control, Single Group Assignment, Safety/Efficacy Study |
Official Title: | Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine: An Open-Label Multicenter Extension Study |
Estimated Enrollment: | 150 |
Study Start Date: | August 2009 |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Kristan Rollins, PharmD | 919-425-8167 | krollins@unither.com |
Principal Investigator: | James Seibold, MD | University of Michigan Scleroderma Program |
Responsible Party: | United Therapeutics ( Kristan Rollins, PharmD ) |
Study ID Numbers: | TDE-DU-202 |
Study First Received: | February 16, 2009 |
Last Updated: | February 19, 2009 |
ClinicalTrials.gov Identifier: | NCT00848107 History of Changes |
Health Authority: | United States: Food and Drug Administration; United Kingdom: Research Ethics Committee; United Kingdom: Medicines and Healthcare Products Regulatory Agency |
systemic sclerosis scleroderma digital ulcers vasculopathy |
Skin Diseases Ulcer Treprostinil Connective Tissue Diseases Scleroderma Scleroderma, Diffuse |
Sclerosis Scleroderma, Systemic Cardiovascular Agents Ischemia Antihypertensive Agents |
Pathologic Processes Skin Diseases Therapeutic Uses Treprostinil Connective Tissue Diseases Scleroderma, Diffuse |
Sclerosis Scleroderma, Systemic Cardiovascular Agents Antihypertensive Agents Pharmacologic Actions |